Novyra Pharmachem postpones its board meeting from April 25 to April 29, 2026.
The meeting was originally scheduled to approve audited financial results for Q4 and FY ending March 31, 2026.
This intimation is a regulatory disclosure made to BSE under SEBI LODR Regulations.